BU-NOT-SET

CONTACT US
When OSD manufacturing goes global
  • Manufacturing
white pills
Insight
Ensuring Reliable HPAPI Supply
  • Drug product
  • Manufacturing
active pharmaceutical ingredient
Insight
De-risking high-potency programmes
  • Drug product
  • Manufacturing
Recipharm lab
Insight
Analytical method development for multivitamin tablets
  • Analytical chemistry
  • Drug product
Female lab worker
Case study
The evolving OSD market: Complexity, capability and collaboration
  • Drug product
  • Manufacturing
Tablets pharma Recipharm
Insight
High-potency APIs and the evolving demands of drug development
  • Drug product
  • Manufacturing
lab person pharma manufacturing
Insight
Safely scaling high potency API manufacturing
  • Drug product
  • Manufacturing
Manufacturing worker Pharma
White paper
From development insight to manufacturing confidence
  • Drug product
  • Manufacturing
Lab worker
Insight
Recipharm Advanced Bio Is Advancing RNA Therapeutics
  • Biologics
  • Manufacturing
RNA vaccines
Insight
Insight
  • Manufacturing
Serialisation: an investment not an expense
Insight
  • Drug product
Solving the solubility setback
Insight
  • Industry trends
Pharmaceutical mega-trends: the rise of consolidation
Insight
  • Manufacturing
What the new Drug Supply Chain Security Act (DSCSA) deadline means for the industry
Insight
  • Manufacturing
Serialisation: is the industry ready?
Insight
  • Manufacturing
Serialisation efforts must push ahead despite deadline extension
Insight
  • Drug product
Metal coordinated pharmaceuticals: a new and promising technology
Insight
  • Drug product
Optimising excipient selection
Insight
  • Manufacturing
Serialisation stragglers: Industry concern for complacency